Filing Details
- Accession Number:
- 0001127602-17-018056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-15 15:26:28
- Reporting Period:
- 2017-05-12
- Filing Date:
- 2017-05-15
- Accepted Time:
- 2017-05-15 15:26:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221496 | George Massaro | 251 Ballardvale Street Wilmington MA 01887 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-12 | 2,436 | $0.00 | 15,831 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $87.85 | 15,731 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $87.94 | 15,631 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $87.98 | 15,531 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.07 | 15,431 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.13 | 15,331 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.28 | 15,231 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.31 | 15,131 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.50 | 15,031 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.51 | 14,931 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 100 | $88.78 | 14,831 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-05-12 | 130 | $88.84 | 14,701 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Consists of 2,436 unvested restricted stock units that vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders.
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
